Skip to main content

Advertisement

SpringerLink
Log in

Leptin down-regulates peroxisome proliferator-activated receptor γ (PPARγ) mRNA levels in primary human monocyte-derived macrophages

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Increased leptin levels are associated with cardiovascular disease in obesity although the mechanism is unknown. Peroxisome proliferator-activated receptor γ (PPARγ) is a key regulator of macrophage lipid metabolism and its activation by thiazolidinediones protects against atherosclerosis. The aim of this study was to assess the effects of human recombinant leptin on PPARγ mRNA levels in primary human macrophages and macrophage-derived foam cells. Leptin treatment (100 ng/ml) for 24 h caused a 41% reduction (p < 0.01) in PPARγ transcript levels in human-derived macrophages. This fall was accompanied by a reduction in the mRNA expression of carnitine palmitoyltransferase (CPT-I) (36%, p < 0.05) and ABCA1 (62%, p < 0.05), whereas CD36 mRNA reduction (34%) was not significant. In macrophage-derived foam cells, leptin at 20 ng/ml reduced PPARγ mRNA levels by 33% (p < 0.01) and CPT-I by 27% (p < 0.05). At this concentration, leptin did not modify the expression of either ABCA1 or CD36. In agreement with these results, intracellular cholesterol ester accumulation was not altered in macrophage-derived foam cells by leptin at 20 ng/ml. We propose that the reduction in PPARγ expression in both macrophages and foam cells may be one of the factors linking high leptin levels and cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Guyton JR: The arterial wall and the atherosclerotic lesion. Curr Opin Lipidol 5: 376–381, 1994

    Google Scholar 

  2. Desvergne B, Wahli W: Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 20: 649–688, 1999

    Google Scholar 

  3. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM: PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241–252, 1998

    Google Scholar 

  4. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B: PPARα and PPARγ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nature Med 7: 53–58, 2001

    Google Scholar 

  5. Ericsson CG, Hamsten A, Nilsson J, Grip L, Svane B, de Faire U: Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 347, 849–853, 1996

    Google Scholar 

  6. Rosen ED, Spiegelman BM: Peroxisome Proliferator-Activated Receptor-γ ligands and atherosclerosis: ending the heartache. J Clin Invest 106: 629–631, 2000

    Google Scholar 

  7. McGill HC, McMahan CA, Malcom GT, Oalmann MC, Strong JP: PDAY Research Group. Relation to glycohemoglobin and adiposity to atherosclerosis in youth. Arterioscler Thromb Vasc Biol 15: 431–438, 1995

    Google Scholar 

  8. Jensen NS: Obesity and cardiovascular disease: is body structure a factor? Curr Opin Lipidol 8: 200–204, 1997

    Google Scholar 

  9. Young JL, Libby P, Schonbeck U: Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88: 554–567, 2002

    Google Scholar 

  10. Haverkate F: Levels of haemostatic factors, arteriosclerosis and cardiovascular disease. Vascul Pharmacol 39: 109–112, 2002

    Google Scholar 

  11. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV: Leptin: The tale of an obesity gene. Diabetes 45: 1455–1462, 1996

    Google Scholar 

  12. Lollmann B, Gruninger S, Stricker-Kongrad A, Chiesi M: Detection and quantification of the leptin receptor splice variants Ob-Ra, b, and, e in different mouse tissues. Biochem Biophys Res Commun 238: 648–652, 1997

    Google Scholar 

  13. Lee FY, Li Y, Yang EK, Yang SQ, Lin HZ, Trush MA, Dannenberg AJ, Diehl AM: Phenotypic abnormalities in macrophages from leptin-deficient, obese mice. Am J Physiol 276: C386–C395, 1999

    Google Scholar 

  14. Söderberg S, Ahrén B, Jansson J-H, Johnson O, Hallmans G, Asplund K, Olsson T: Leptin is associated with increased risk of myocardial infarction. J Intern Med 246: 409–418, 1999

    Google Scholar 

  15. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, Stevenson JC: Hyperleptinemia as a component of a metabolic syndrome of cardiovascular disease. Arterioscler Thromb Vasc Biol 18: 928–933, 1998

    Google Scholar 

  16. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N: Plasma leptin and the risk of cardiovascular disease in the west of Scotland Coronary Prevention Study (WOSCOPS). Circulation 104: 3052–3056, 2001

    Google Scholar 

  17. Vázquez M, Zambón D, Hernández Y, Adzet T, Merlos M, Ros E, Laguna JC: Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia. Br J Clin Pharmacol 45: 265–269, 1998

    Google Scholar 

  18. Basu SK, Goldstein JL, Anderson RG, Brown MS: Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci USA 73: 3178–3182, 1976

    Google Scholar 

  19. Freeman WM, Walker SJ, Kent EV: Quantitative RT-PCR: Pitfalls and Potential. Biotechniques 26: 112–125, 1999

    Google Scholar 

  20. Klansek JJ, Yancey P, St Clair RW, Fischer RT, Johnson WJ, Glick JM: Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters. J Lipid Res 36: 2261–2266, 1995

    Google Scholar 

  21. Guardiola F, Codony R, Rafecas M, Boatella J: Selective gas chromatographic determination of cholesterol in eggs. J Am Oil Chem Soc 71: 867–871, 1994

    Google Scholar 

  22. Zhou Y-T, Whang Z-W, Higa M, Newgard CB, Unger RH: Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA 96: 2391–2395, 1999

    Google Scholar 

  23. Pelton PD, Zhou L, Demarest KT, Burris TP: PPARγ activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem Biophys Res Commun 261: 456–458, 1999

    Google Scholar 

  24. Wang X, Reape TJ, Li X, Rayner K, Webb CL, Burnand KG, Lysko PG: Induced expression of adipophilin mRNA in human macrophages stimulated with oxidized low-density lipoprotein and in atherosclerotic lesions. FEBS Lett 462: 145–150, 1999

    Google Scholar 

  25. Barter PJ, Rye KA: High density lipoproteins and coronary heart disease. Atherosclerosis 121: 1–5, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unitat de Farmacologia, Departament de Farmacologia i Química Terapèutica, Facultat de Farmàcia, University of Barcelona, Spain

    Àgatha Cabrero, Marta Cubero, Gemma Llaverías, Marta Alegret, Rosa Sánchez, Juan Carlos Laguna & Manuel Vázquez-Carrera

  2. Unitat de Farmacologia, Facultat de Farmàcia, Diagonal 643, E-08028, Barcelona, Spain

    Manuel Vázquez-Carrera

Authors
  1. Àgatha Cabrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marta Cubero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gemma Llaverías
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marta Alegret
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rosa Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Juan Carlos Laguna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Manuel Vázquez-Carrera
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manuel Vázquez-Carrera.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cabrero, À., Cubero, M., Llaverías, G. et al. Leptin down-regulates peroxisome proliferator-activated receptor γ (PPARγ) mRNA levels in primary human monocyte-derived macrophages. Mol Cell Biochem 275, 173–179 (2005). https://doi.org/10.1007/s11010-005-1353-8

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-005-1353-8

Keywords

Search

Navigation